Bausch Health
370 hedge funds and large institutions have $5.9B invested in Bausch Health in 2022 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 120 increasing their positions, 111 reducing their positions, and 62 closing their positions.
72% more call options, than puts
Call options by funds: $437M | Put options by funds: $254M
8% more repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 111
0.29% more ownership
Funds ownership: 71.53% → 71.82% (+0.29%)
5% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 62
2% less funds holding
Funds holding: 377 → 370 (-7)
17% less capital invested
Capital invested by funds: $7.07B → $5.9B (-$1.17B)
19% less funds holding in top 10
Funds holding in top 10: 21 → 17 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parallax Volatility Advisers
San Francisco,
California
|
+$60.2M |
| 2 |
Jane Street
New York
|
+$50M |
| 3 |
GAM
Goldentree Asset Management
New York
|
+$49.5M |
| 4 |
LCM
Laurion Capital Management
New York
|
+$41.8M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$41.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
-$102M |
| 2 |
GCM
Glenview Capital Management
New York
|
-$79.3M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$33M |
| 4 |
VH
ValueAct Holdings
San Francisco,
California
|
-$29M |
| 5 |
PIP
Permian Investment Partners
Dallas,
Texas
|
-$28.5M |
BHC Hedge Fund Activity: Q1 2022 in Review
370 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2022, worth a combined $5.9B — down 17% from $7.07B a quarter earlier.
Sellers outnumbered buyers: 62 funds closed out of BHC and 59 opened new positions — a net loss of 3 holders — while 111 trimmed existing stakes and 120 added.
The largest buyer was Parallax Volatility Advisers, opening a new position worth an estimated $60.2M. The largest seller was Clear Street, exiting entirely with an estimated $102M sold.
- 370 institutional investors held Bausch Health (BHC) as of Q1 2022, down from 377 in Q4 2021.
- Funds reported $5.9B of Bausch Health stock for Q1 2022, down 17% quarter-over-quarter.
- 59 funds opened new Bausch Health positions in Q1 2022 and 62 closed out, a net change of -3 holders.
- The largest Bausch Health buyer in Q1 2022 was Parallax Volatility Advisers, an estimated $60.2M added.
- The largest Bausch Health seller in Q1 2022 was Clear Street, an estimated $102M sold.
Based on aggregated 13F filings for Q1 2022.